Canada Pension Plan Investment Board
AKBA icon

Canada Pension Plan Investment Board’s Akebia Therapeutics AKBA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Buy
323,600
+36,100
+13% +$43K ﹤0.01% 1381
2026
Q1 		$400K Sell
287,500
-35,400
-11% -$48.6K ﹤0.01% 1311
2025
Q4 		$520K Buy
+322,900
New +$676K ﹤0.01% 1292

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Canada Pension Plan Investment Board's AKBA Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Akebia Therapeutics (AKBA) stake by 13% in Q2 2026, buying an estimated $43K and bringing the position to 323,600 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

Canada Pension Plan Investment Board first reported a position in AKBA in Q4 2025 and has held it in 3 quarters since. The position peaked at $520K in Q4 2025. 170 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Canada Pension Plan Investment Board held 323,600 shares of Akebia Therapeutics worth $369K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 36,100 Akebia Therapeutics shares in Q2 2026, an estimated $43K.
  • Akebia Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1381 holding.
  • Canada Pension Plan Investment Board first reported a position in Akebia Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Canada Pension Plan Investment Board's Akebia Therapeutics position peaked at $520K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.